Loading...
OTCM
LBTTF
Market cap20mUSD
, Last price  
USD
Name

LBT Innovations Ltd

Chart & Performance

D1W1MN
OTCM:LBTTF chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
26.51%
Rev. gr., 5y
33.25%
Revenues
1m
-41.09%
03,394,0971,868,0001,992,0003,776,000500,000842,0004,339,0003,991,0002,367,0007,726,000330,000951,000299,0001,162,0001,123,0002,128,0002,132,0001,256,000
Net income
-4m
L-83.40%
0965,338722,000337,0001,488,000-1,162,000-1,156,000531,000292,000321,0003,577,000-5,133,000-2,685,000-4,350,000-5,636,000-7,260,000-6,641,000-22,524,000-3,740,000
CFO
-4m
L+162.73%
0000000-2,069,0002,436,0003,048,0007,874,000-657,0001,325,000-807,000-1,855,000-2,673,000-4,949,000-1,398,000-3,673,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

LBT Innovations Limited is dedicated to conceiving, advancing, and bringing to market cutting-edge technological solutions for the healthcare and laboratory sectors. The company's operations span various international locations, including Australia, Switzerland, the United States, the United Kingdom, and Germany. Its offerings include MicroStreak, an automated system designed for streaking and inoculating culture plates, and the Automated Plate Assessment System (APAS), a foundational technology that streamlines the screening and interpretation of culture plates. The firm is also actively developing several other innovations: Automated Gram Strain Assessment, intended for the automated interpretation of gram stain image analysis; WoundVue, an AI-powered tool assisting clinicians with the evaluation and care of chronic wounds; Automated Plate Assessment System Pharma, which leverages sophisticated artificial intelligence image analysis algorithms to automatically identify microbial growth in environmental monitoring applications; and specialized devices capable of detecting biofilms within mammalian tissue. Established in 2004, LBT Innovations Limited maintains its headquarters in Adelaide, Australia.
IPO date
Jul 31, 2006
Employees
28
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT